Cambium Bio Limited

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.cambium.bio

Country

Australia

Exchange

ASX

Bella Vista, Australia

Cambium Bio Limited, a clinical-stage regenerative medicine company focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease.

It also develops Progenza, a stem cell platform for knee osteoarthritis and tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.

Key Stats

52-Week Range

A$0.29A$0.60

Beta-0.13

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.14

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.